Expression of recombinant puroindolines for the treatment of staphylococcal skin infections (acne vulgaris)

J Biotechnol. 2007 Feb 20;128(3):606-14. doi: 10.1016/j.jbiotec.2006.11.004. Epub 2006 Nov 16.

Abstract

Puroindolines are antimicrobial peptides that occur in wheat seed, and are characterized by broad antimicrobial activity. We describe the heterologous expression of puroindoline A and B in the Origami strain of Escherichia coli. The recombinant puroindolines showed the same antimicrobial activity on Staphylococcus epidermidis as compared to the native peptides (MIC(90)=30microgml(-1)). The bactericidal activity was 125microgml(-1) for recombinant puroindoline A and 42microgml(-1) for recombinant puroindoline B. Neither protein shows in vitro haemolytic activity or toxicity towards the murine macrophage cell line J774, but they are able to kill intracellular staphylococci. Our preliminary results suggest that recombinant puroindolines deserve further attention as alternatives to the conventional antibiotics in the control of S. epidermidis skin infections.

MeSH terms

  • Acne Vulgaris / drug therapy*
  • Animals
  • Anti-Infective Agents / isolation & purification
  • Anti-Infective Agents / metabolism
  • Anti-Infective Agents / therapeutic use
  • Cells, Cultured
  • Drug Evaluation, Preclinical
  • Escherichia coli
  • Green Fluorescent Proteins / chemistry
  • Hemolysis / drug effects
  • Mice
  • Microbial Sensitivity Tests
  • Plant Proteins / metabolism*
  • Plant Proteins / therapeutic use
  • Protein Engineering
  • Recombinant Proteins / isolation & purification
  • Recombinant Proteins / metabolism*
  • Recombinant Proteins / therapeutic use*
  • Staphylococcal Skin Infections / drug therapy*
  • Staphylococcus epidermidis* / drug effects

Substances

  • Anti-Infective Agents
  • Plant Proteins
  • Recombinant Proteins
  • puroindoline protein, Triticum aestivum
  • Green Fluorescent Proteins